Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Psoriasis
Sort By
Newest First
Sign in
1 / 1
1 / 1
Clinical Trials
Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study
UCB
PR-M03-19-NI-016
Mar 07, 2019
FDA Approval
Bausch Health's BRYHALI™(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Bausch Health Companies Inc.
PR-M10-18-NI-033
Oct 10, 2018
FDA
Johnson & Johnson Gets FDA Nod for New Treatment for Plaque Psoriasis
Nigel Walker
Nice Insight
PAO-M07-17-NI-023
Jul 21, 2017
